Orlistat

Drug Levels and Effects:




Summary of Use during Lactation:


Because orlistat is poorly absorbed orally, it is unlikely that any orlistat is excreted into milk or absorbed by the infant. Therefore, it is unlikely to adversely affect the breastfed infant.


Drug Levels:


Maternal Levels.

Relevant published information was not found as of the revision date.

Infant Levels.

Relevant published information was not found as of the revision date.


Effects in Breastfed Infants:


Relevant published information was not found as of the revision date.


Possible Effects on Lactation:


Relevant published information was not found as of the revision date.


References:






Substance Identification:




Substance Name:

Orlistat

CAS Registry Number:

96829-58-2

Drug Class:


  • Enzyme Inhibitors

  • Anti-Obesity Agents


  • Administrative Information:




    LactMed Record Number:


    886


    Last Revision Date:


    Disclaimer:Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.